{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T05:03:48Z","timestamp":1696914228904},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.2515\/therapie\/2009043","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T09:56:32Z","timestamp":1254822992000},"page":"269-277","source":"Crossref","is-referenced-by-count":4,"title":["Comparaison des donn\u00e9es analytiques et anamnestiques des consommations de drogues et psychotropes chez des usagers d\u2019opiac\u00e9s en traitement de substitution. \u00c9tude de faisabilit\u00e9"],"prefix":"10.1016","volume":"64","author":[{"given":"Joanna","family":"Bourgine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reynald","family":"Le Boisselier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magalie","family":"Paillet-Loilier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Albessard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Lelong-Boulouard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Vigneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Jolliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00e8le","family":"Debruyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Coquerel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2009043_bb0005","unstructured":"Observatoire fran\u00e7ais des drogues et des toxicomanies. Drogues, chiffres cl\u00e9s. http:\/\/www.academie-medecine.fr\/UserFiles\/File\/rapports_thematiques\/drogues\/ofdt2008(1).pdf."},{"key":"10.2515\/therapie\/2009043_bb0010","author":"Association Nationale des Intervenants en Toxicomanie et addictologie. Traitements de substitution \u00e0 la bupr\u00e9norphine : l\u2019exp\u00e9rience fran\u00e7aise"},{"key":"10.2515\/therapie\/2009043_bb0015","doi-asserted-by":"crossref","first-page":"968","DOI":"10.7326\/0003-4819-134-10-200105150-00011","article-title":"A comparison study of multiple measures of adherence to HIV protease inhibitors","volume":"134","author":"Liu","year":"2001","journal-title":"Ann Int Med"},{"key":"10.2515\/therapie\/2009043_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Moriski","year":"1986","journal-title":"Med Care"},{"key":"10.2515\/therapie\/2009043_bb0025","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(75)92192-3","article-title":"Randomized clinical trial of strategies for improving medication compliance in primary hypertension","volume":"1","author":"Sackett","year":"1975","journal-title":"Lancet"},{"key":"10.2515\/therapie\/2009043_bb0030","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.addbeh.2006.06.034","article-title":"Nonreporting of cannabis use: predictors and relationship to treatment outcome in methadone maintained patients","volume":"32","author":"Ghitza","year":"2006","journal-title":"Addict Behav"},{"key":"10.2515\/therapie\/2009043_bb0035","first-page":"123","article-title":"Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?","volume":"9","author":"Manchikanti","year":"2006","journal-title":"Pain Physician"},{"key":"10.2515\/therapie\/2009043_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jsat.2006.11.008","article-title":"Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing","volume":"33","author":"Jaffee","year":"2007","journal-title":"J Subst Abuse Treat"},{"key":"10.2515\/therapie\/2009043_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/000456329503200203","article-title":"Screening for drugs of abuse. (I): Opiates, amphetamines and cocaine","volume":"32","author":"Braithwaite","year":"1995","journal-title":"Ann Clin Biochem"},{"key":"10.2515\/therapie\/2009043_bb0050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/000456329703400502","article-title":"Screening for drugs of abuse. (II): Cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs","volume":"34","author":"Simpson","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"10.2515\/therapie\/2009043_bb0055","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1515\/CCLM.2004.250","article-title":"Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and\/or doping control","volume":"42","author":"Maurer","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.2515\/therapie\/2009043_bb0060","series-title":"Analyses chimiques. M\u00e9thodes et techniques instrumentales modernes","first-page":"462","author":"Roussac","year":"2004"},{"key":"10.2515\/therapie\/2009043_bb0065","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jpba.2006.02.020","article-title":"Liquid chromatographic-electrospray ionization mass spectrometric quantitative analysis of buprenorphine, norbuprenorphine, nordiazepam and oxazepam in rat plasma","volume":"41","author":"Pirnay","year":"2006","journal-title":"J Pharm and Biomed Analysis"},{"key":"10.2515\/therapie\/2009043_bb0070","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1373\/clinchem.2006.069054","article-title":"Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine","volume":"52","author":"Pirnay","year":"2006","journal-title":"Clin Chem"},{"key":"10.2515\/therapie\/2009043_bb0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jat\/19.3.157","article-title":"Comparison of the hydrolysis rates of morphine-3-glucuronide and morphine-6-glucuronide with acid and \u03b2-glucuronidase","volume":"19","author":"Romberg","year":"1995","journal-title":"J Anal Toxicol"},{"key":"10.2515\/therapie\/2009043_bb0080","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/jat\/30.8.570","article-title":"Incomplete recovery of prescription opioids in urine using enzymatic hydrolysis of glucuronide metabolites","volume":"30","author":"Wang","year":"2006","journal-title":"J Anal Toxicol"},{"key":"10.2515\/therapie\/2009043_bb0085","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/clinchem\/48.11.2047","article-title":"Enzymatic hydrolysis improves the sensitivity of emit screening for urinary benzodiazepines","volume":"48","author":"Borrey","year":"2002","journal-title":"Clin Chem"},{"key":"10.2515\/therapie\/2009043_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jat\/29.3.193","article-title":"Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography-mass spectrometry","volume":"29","author":"Klette","year":"2005","journal-title":"J Anal Toxicol"},{"key":"10.2515\/therapie\/2009043_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0740-5472(01)00189-1","article-title":"Practice-based buprenorphine maintenance treatment (BMT): how do french healthcare providers manage the opiate-addicted patients?","volume":"21","author":"Vignau","year":"2001","journal-title":"J Substance Abuse treatment"},{"key":"10.2515\/therapie\/2009043_bb0100","unstructured":"Gandilhon M. Le petit trafic de Coca\u00efne en France. Tendances n\u25e6 53. Avril 2007. OFDT http:\/\/www.ofdt.fr\/ofdtdev\/live\/publi."},{"key":"10.2515\/therapie\/2009043_bb0105","series-title":"OCRTIS, Nanterre","article-title":"Usage et trafic des produits stup\u00e9fiants en France en 2005","author":"Office central pour la r\u00e9pression du trafic illicite des stup\u00e9fiants (OCRTIS)","year":"2006"},{"key":"10.2515\/therapie\/2009043_bb0110","unstructured":"Observatoire fran\u00e7ais des drogues et des toxicomanies. Coca\u00efne et crack : consommation. http:\/\/www.ofdt.fr\/ofdtdev\/live\/produits\/cocaine\/conso.html#aff_rech."},{"key":"10.2515\/therapie\/2009043_bb0115","author":"Observatoire fran\u00e7ais des drogues et des toxicomanies"},{"key":"10.2515\/therapie\/2009043_bb0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/clinchem\/47.2.301","article-title":"Detection of acetylcodeine in urine as an indicator of illicit heroin use: method validation and results of a pilot study","volume":"47","author":"Staub","year":"2001","journal-title":"Clin Chem"},{"key":"10.2515\/therapie\/2009043_bb0125","series-title":"Toxicologie et Pharmacologie m\u00e9dicol\u00e9gales","first-page":"335","article-title":"Opiac\u00e9s et opio\u00efdes","author":"P\u00e9pin","year":"1998"},{"key":"10.2515\/therapie\/2009043_bb0130","series-title":"Toxicologie et Pharmacologie m\u00e9dicol\u00e9gales","first-page":"431","author":"Coca\u00efne","year":"1998"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716306230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716306230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T20:32:23Z","timestamp":1590179543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716306230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0040595716306230"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2009043","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}